Investor Presentaiton slide image

Investor Presentaiton

Médica Sur, S.A.B. and Subsidiaries STATEMENT CONSOLIDATED RESULTS AND OTHER COMPREHENSIVE RESULTS Years ending on December 31, 2016 and 2015 (Mexican pesos) Service revenue Service costs Consolidated gross profit Notes 2016 2015 $ 2,590,272,612 2,278,751,602 1,794,333,517 1,569,274,825 795,939,095 709,476,777 Médica Sur, S.A.B. and Subsidiaries CONSOLIDATED STATEMENT OF CASH FLOWS Years ending on December 31, 2016 and 2015 (Mexican pesos) Cash flows from operating activities: Total pre-tax profit Adjustments for: Net cost of the period for employee benefits Notes 2016 2015 $ 199,730,800 349,579,120 Expenses: Sales and administrative expenses Other (income) expenses, net 24 588,202,883 358,818,301 (2,922,504) 19,615,186 Total expenses 585,280,379 378,433,487 Consolidated operating income 210,658,716 331,043,290 Financial income and costs Foreign currency gain, net 15,031,944 7,873,078 Participation in the results of affiliated companies 15 (4,077,369) Impairment of investment in affiliated company shares 15 y 24 10,401,840 Depreciation and amortization 13 y 14 Losses in the sale of transportation equipment and other assets Interest income 325,247,154 107,917 121,748,868 (15,110,169) 193,823 (10,910,475) Interest expenses Interest income 839,523 (26,877,608) 15,110,169 3,627,898 10,910,475 (Costs) Financial income, net 25 (10,927,916) 14,458,461 Participation in the results of affiliated companies 15 Consolidated operating income before tax 199,730,800 349,579,120 Profit tax 19 53,519,878 108,461,781 Consolidated operating income $ 146,210,922 241,117,339 Other comprehensive results Net actuarial profits (losses) from income tax 18 Consolidated comprehensive income $ Net comprehensive income attributable to: Controlling interests $ Non-controlling interests 142,634,010 241,018,529 3,576,912 98,810 $ 146,210,922 241,117,339 (79,912) 4,077,369 1,936,970 (306,550) 148,147,892 240,810,789 Entries from financing activities: Interest expenses Subtotal Accounts receivable, net Médica Sur Clinical Foundation, A. C. Other accounts receivable Inventories, net Prepaid insurance Suppliers Taxes and accrued expenses Provisions for contingent liabilities Net cash flows from operating activities Paid taxes Interest paid Net flows generated from operating activities Investment activities: Increase (decrease) in other non-current assets, net Interest collected 26,877,608 79,912 551,885,254 474,888,797 (4,108,574) (4,277,881) 95,606 (115,305) (42,821,646) 1,943,706 (24,208,083) (9,102,220) (10,172,043) (737,095) (204,087,506) (29,803,571) 80,594,487 26,664,296 15,436,374 1,800,000 362,613,869 461,260,727 (143,192,000) (133,373,575) (20,639,728) (79,912) 198,782,141 327,807,240 4,837,391 15,110,169 Revenue from the sale of properties, furnishings and equipment Acquisitions of property, furnishings, equipment and investment properties Dividends received from investments in affiliated companies Business acquisitions 13 y 14 (2,073,299) 10,910,475 767,963 (230,325,263) (228,355,320) 6,527,202 6 Net cash flows used in investment activities Financing activities (1,447,493,000) (1,657,870,703) (212,222,979) Consolidated comprehensive income attributable to: Loans obtained Controlling interests $ Non-controlling interests 144,570,980 3,576,912 240,711,979 Dividends paid 98,810 Net cash flows generated by (used in) financing activities SA $ 148,147,892 240,810,789 Basic and diluted earnings per share Weighted average number of shares $ 1.19 1.95 Cash and cash equivalents: 22 123,281,750 123,281,750 Net decrease (increase) in cash and cash equivalents At the beginning of the year At the end of the year 17 1,285,000,000 21 (80,729,079) (100,632,547) 1,204,270,921 (100,632,547) (254,817,641) 14,951,714 9 $ 359,127,708 344,175,994 104,310,067 359,127,708 See the relevant notes to the Consolidated Financial Statements. 36 16 // ANNUAL REPORT See the relevant notes to the Consolidated Financial Statements. 3 7
View entire presentation